Prostate cancer
Conditions
Interventions
Perform a transperineal prostate needle biopsy the day after admission.
Sponsors
Nagoya University Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Patients with localized prostate cancer with a serum PSA level of >4.0 ng / mL and <20 ng / ml, suspected of having Significant cancer by MRI.
Exclusion criteria
Exclusion criteria: Exclude patients who do not meet the above eligibility criteria. Patients who have difficulty inserting a transrectal ultrasound probe due to anal stenosis. Diabetic patients who are positive for urinary ketone bodies, have fasting blood glucose of 200 mg / dL or higher, and have postprandial blood glucose of 300 mg / dL or higher. Patients with a foci of infection in the perineum, which is the puncture site. Patients with lesions of a diameter of 10 mm or more on MRI which detected on transrectal ultrasonography and judged to be easy to biopsy by urologist.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection rate of Significant Cancer in transperineal prostate needle biopsy by Biojet system | — |
Countries
Japan
Contacts
Public ContactTakashi Fujita
Nagoya University Graduate School of Medicine Urology
Outcome results
None listed